相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study
Dae Hyun Kim et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Implications of the Propensity Score Matching Paradox in Pharmacoepidemiology
John E. Ripollone et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2018)
Reduced Mortality With Sodium-Glucose Cotransporter-2 Inhibitors in Observational Studies Avoiding Immortal Time Bias
Samy Suissa
CIRCULATION (2018)
Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records
Elisabetta Patorno et al.
DIABETES OBESITY & METABOLISM (2018)
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
Subodh Verma et al.
DIABETOLOGIA (2018)
Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study
Elisabetta Patorno et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study
Elisabetta Patorno et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Use of Health Care Databases to Support Supplemental Indications of Approved Medications
Michael Fralick et al.
JAMA INTERNAL MEDICINE (2018)
Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias?
Samy Suissa
DIABETES CARE (2018)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study
Seoyoung C. Kim et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)
Mikhail Kosiborod et al.
CIRCULATION (2017)
Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases
S. V. Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B. Green et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Silvio E. Inzucchi et al.
DIABETES CARE (2015)
Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations
Elisabetta Patorno et al.
DIABETOLOGIA (2014)
Metrics for covariate balance in cohort studies of causal effects
Jessica M. Franklin et al.
STATISTICS IN MEDICINE (2014)
One-to-many propensity score matching in cohort studies
Jeremy A. Rassen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
A systematic review of validated methods for identifying heart failure using administrative data
Jane S. Saczynski et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
A combined comorbidity score predicted mortality in elderly patients better than existing scores
Joshua J. Gagne et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
A basic study design for expedited safety signal evaluation based on electronic healthcare data
Sebastian Schneeweiss
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data
Sebastian Schneeweiss et al.
EPIDEMIOLOGY (2009)
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
Peter C. Austin
STATISTICS IN MEDICINE (2009)
分享论文
